Publisher Correction: Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial
Jessica S.W. Borgers(The Netherlands Cancer Institute), Divya Lenkala(BioNTech (United States)), Victoria Kohler(BioNTech (United States)), Emily Jackson(BioNTech (United States)), Matthijs D. Linssen(The Netherlands Cancer Institute), Sebastian Hymson(BioNTech (United States)), Brian J. McCarthy(BioNTech (United States)), E Cosgrove(BioNTech (United States)), Kristen N. Balogh(BioNTech (United States)), Ekaterina Esaulova(BioNTech (United States)), Kimberly Starr(BioNTech (Germany)), Yvonne Ware(BioNTech (United States)), Sebastian Klobuch(The Netherlands Cancer Institute), Tracey Sciuto(BioNTech (United States)), Xi Chen(BioNTech (United States)), Gauri Mahimkar(BioNTech (United States)), Joong-Hyuk Sheen(BioNTech (United States)), Suchitra Ramesh(BioNTech (United States)), Sofie Wilgenhof(The Netherlands Cancer Institute), Johannes V. van Thienen(The Netherlands Cancer Institute), Karina C. Scheiner(The Netherlands Cancer Institute), Inge Jedema(The Netherlands Cancer Institute), Michael S. Rooney(BioNTech (United States)), Jesse Z. Dong(BioNTech (United States)), John Srouji(BioNTech (United States)), Vikram R. Juneja(BioNTech (United States)), Christina M. Arieta(BioNTech (United States)), Bastiaan Nuijen(The Netherlands Cancer Institute), Claudia Gottstein(BioNTech (Germany)), Olivia Finney(BioNTech (United States)), Kelledy Manson(BioNTech (United States)), Cynthia M. Nijenhuis(The Netherlands Cancer Institute), Richard B. Gaynor(BioNTech (United States)), Mark DeMario(BioNTech (United States)), John B.A.G. Haanen(Oncode Institute), Marit M. van Buuren(BioNTech (United States))
Cited by 0Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis